Roy Lobb
InvestorVenture Partner at Advent Life Sciences
Massachusetts
Writes $25K – $5M checks · typically $1M
About
Roy Lobb joined Advent in 2015 with over 25 years of experience in drug discovery and development. He earned a D.Phil. from Oxford University and was previously an Assistant Professor of Pathology at Harvard Medical School, then spent 15 years at Biogen Inc, where he served as Senior Director of Exploratory Research and identified the pathway underlying the development of the multiple sclerosis drug Tysabri. Since leaving Biogen, he has cofounded several biotechnology companies.
Invests in
Biotech
Experience
- Aleta Biotherapeuticsdirector and cofoundercurrent2015 — presentGreater Boston Area
- Avila Therapeuticsconsultant & co-founder2007 — 2012
- BiogenSenior director Discovery Research1987 — 2001
Education
- University of OxfordDPhil, Chemistry1968 — 1974
Same school
Also attended University of Oxford771
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures
+ 765 more
Shared employers
Also worked at Biogen27
Jigar RaythathaInvestor at Third Rock VenturesKevin StarrInvestor at Third Rock VenturesRichard RansohoffVenture Partner at Third Rock VenturesIsaiah Baril-DoreInvestor at Index VenturesSteve HoltzmanBio Advisor at Amplify PartnersZach MartinsAssistant Controller at Pillar VC
+ 21 more
Investments
Board seats
Aleta Biotherapeutics
Investor
Albor BiologicsAlvos TherapeuticsAvila Therapeutics
Per the firm's website.
Colleagues at Advent Life Sciences
Alain Huriez
Venture Partner at Advent Life Sciences
Alan Walts
Venture Partner at Advent Life Sciences
Andrea Beesley
Team Assistant at Advent Life Sciences
Bonita Theara
Executive Assistant at Advent Life Sciences
Dominic Schmidt
General Partner at Advent Life Sciences
Don Drakeman
Distinguished Research Professor, biotech entrepreneur, and venture partner
Fraser Murray
Head of Scientific Evaluation at Advent Life Sciences
Gail Jermyn
Investor Relations Partner at Advent Life Sciences